Regenxbio RGNX
NASDAQ RGNX
$8.47 +0.78 (+10.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Regenxbio (RGNX) Return on Equity [ROE] (2015 - 2026)

Updated

Regenxbio (RGNX) posted Return on Equity [ROE] of -423.28% for Q2 2026, down 351.24 percentage points from -72.04% a year earlier but up 45.30 percentage points from the prior quarter.

Analysis

Regenxbio (RGNX) Return on Equity [ROE] (2015 - 2026) Analysis & Trends

For FY2025, Regenxbio's Return on Equity [ROE] came in at -107.05%, down 27.56 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -80.17 percentage points (FY2020 to FY2025).
  • In prior years, Regenxbio's Return on Equity [ROE] was -79.49% in FY2024 (-15.84 pp), -63.65% in FY2023 (-19.87 pp), -43.78% in FY2022 (-66.17 pp) and 22.39% in FY2021 (+49.26 pp).
  • Quarterly Return on Equity [ROE] has run from a low of -468.58% in Q1 2026 to a high of 20.86% in Q4 2021 over five years.
  • On a year-over-year basis, Return on Equity [ROE] has declined in each of the last five quarters, with an average year-over-year change of -106.04 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2022, with a gain of 56.19 percentage points; the weakest was Q1 2026, with a drop of 409.44 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -468.58% (Q1 2026), -146.84% (Q4 2025) and -94.93% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Regenxbio 508.48 Mn -228.57 Mn - -159.66%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -159.66%
Jun 30, 2026 -423.07%
Mar 31, 2026 -468.36%
Dec 31, 2025 -146.74%
Sep 30, 2025 -94.89%
Jun 30, 2025 -71.35%
Mar 31, 2025 -58.15%
Dec 31, 2024 -79.64%
Sep 30, 2024 -71.41%
Jun 30, 2024 -63.13%
Mar 31, 2024 -71.68%
Dec 31, 2023 -74.84%
Sep 30, 2023 -64.94%
Jun 30, 2023 -61.88%
Mar 31, 2023 -55.02%
Dec 31, 2022 -54.29%
Sep 30, 2022 9.70%
Jun 30, 2022 11.89%
Mar 31, 2022 12.65%
Dec 31, 2021 20.71%
API Access

Regenxbio Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RGNX&period=max&api_key=YOUR_API_KEY